Search
C4 Therapeutics Inc
CCCCAdd to Watchlist
3.480USD
-0.180-4.92%
Close 07-31 16:00（ET）Quotes delayed by 15 min
384.77MMarket Cap
LossP/E TTM
C4 Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of C4 Therapeutics Inc is 7.25, ranking 192 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.18, which is -86.51% below the recent high of -0.43 and -34.19% above the recent low of -4.27.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.